Pharvaris (PHVS) Times Interest Earned (2020 - 2024)

Pharvaris (PHVS) posted Times Interest Earned of $0.0 for Q3 2024, down 99.97% on a QoQ basis from $1.0 in Q4 2023.

Pharvaris (PHVS) Times Interest Earned (2020 - 2024) Analysis & Trends

Pharvaris' Times Interest Earned history runs 5 years deep, the most recent figure standing at $0.0 for Q3 2024.

Quarterly Times Interest Earned changed N/A year-over-year to $0.0 in Q3 2024, while the trailing twelve-month figure through Sep 2024 was $2.0 (down 100.0% YoY) and the FY2023 annual result came in at $0.0, up 100.0% from the prior year.
Times Interest Earned was $0.0 for Q3 2024 at Pharvaris, down from $1.0 in the prior quarter.
Across five years, Times Interest Earned topped out at $1149.7 in Q4 2022 and bottomed at -$859.6 million in Q3 2022.
A 5-year average of -$71.6 million and a median of -$25.8 in 2021 frame the typical range for Times Interest Earned.
Peak annual rise in Times Interest Earned reached 184.09% in 2022, while the deepest fall reached 507762871.15% in 2022.
Pharvaris' Times Interest Earned stood at -$135.02 in 2020, then tumbled by 976.57% to -$1453.6 in 2021, then jumped by 179.09% to $1149.7 in 2022, then slumped by 99.91% to $1.0 in 2023, then slumped by 99.97% to $0.0 in 2024.
Business Quant data shows PHVS's Times Interest Earned at $0.0 in Q3 2024, $1.0 in Q4 2023, and $1149.7 in Q4 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Times Interest Earned (Qtr)
1	Oculis Holding AG	67,072.09 Bn	67,072.09 Bn	-	658.42
2	Nanobiotix	1,894.61 Bn	1,894.55 Bn	-	-
3	Akari Therapeutics	1,014.18 Bn	1,014.18 Bn	-	-157.58
4	BeOne Medicines	471.64 Bn	466.85 Bn	1.35 Bn	7.60
5	Vertex Pharmaceuticals	121.72 Bn	114.47 Bn	2.59 Bn	2.71
6	Regeneron Pharmaceuticals	68.28 Bn	59.52 Bn	3.31 Bn	22.72
7	Belite Bio	61.40 Bn	61.40 Bn	-	-
8	Argenx Se	56.94 Bn	56.94 Bn	1.18 Bn	-
9	Revolution Medicines	37.37 Bn	37.37 Bn	-	-0.38
10	Pharvaris	2.22 Bn	1.94 Bn	-	-

Download Data